TR201720293A2 - Tolperi̇zon ve non-selekti̇f cox i̇nhi̇bi̇törü kombi̇nasyonlari - Google Patents

Tolperi̇zon ve non-selekti̇f cox i̇nhi̇bi̇törü kombi̇nasyonlari Download PDF

Info

Publication number
TR201720293A2
TR201720293A2 TR2017/20293A TR201720293A TR201720293A2 TR 201720293 A2 TR201720293 A2 TR 201720293A2 TR 2017/20293 A TR2017/20293 A TR 2017/20293A TR 201720293 A TR201720293 A TR 201720293A TR 201720293 A2 TR201720293 A2 TR 201720293A2
Authority
TR
Turkey
Prior art keywords
tolperizone
sodium
selective cox
weight
tablet
Prior art date
Application number
TR2017/20293A
Other languages
English (en)
Turkish (tr)
Inventor
Türkkan Seyhan
Türkyilmaz Ali̇
Pehli̇van Akalin Nur
Misirli Melda
Tuncay Emi̇ne
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/20293A priority Critical patent/TR201720293A2/tr
Priority to PCT/TR2018/050801 priority patent/WO2019190432A2/en
Priority to EP18911384.8A priority patent/EP3723735A4/de
Publication of TR201720293A2 publication Critical patent/TR201720293A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
TR2017/20293A 2017-12-13 2017-12-13 Tolperi̇zon ve non-selekti̇f cox i̇nhi̇bi̇törü kombi̇nasyonlari TR201720293A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/20293A TR201720293A2 (tr) 2017-12-13 2017-12-13 Tolperi̇zon ve non-selekti̇f cox i̇nhi̇bi̇törü kombi̇nasyonlari
PCT/TR2018/050801 WO2019190432A2 (en) 2017-12-13 2018-12-12 Tolperisone and non-selective cox inhibitor combinations
EP18911384.8A EP3723735A4 (de) 2017-12-13 2018-12-12 Tolperison und nicht-selektive cox-inhibitorkombinationen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/20293A TR201720293A2 (tr) 2017-12-13 2017-12-13 Tolperi̇zon ve non-selekti̇f cox i̇nhi̇bi̇törü kombi̇nasyonlari

Publications (1)

Publication Number Publication Date
TR201720293A2 true TR201720293A2 (tr) 2019-06-21

Family

ID=67952207

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/20293A TR201720293A2 (tr) 2017-12-13 2017-12-13 Tolperi̇zon ve non-selekti̇f cox i̇nhi̇bi̇törü kombi̇nasyonlari

Country Status (3)

Country Link
EP (1) EP3723735A4 (de)
TR (1) TR201720293A2 (de)
WO (1) WO2019190432A2 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040204413A1 (en) * 2001-01-26 2004-10-14 Joaquina Faour Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant
HUP0700828A2 (en) * 2007-12-20 2010-01-28 Richter Gedeon Nyrt Transdermal pharmaceutical compositions containing tolperisone alone and in combination
CN102438597A (zh) 2009-03-09 2012-05-02 丁内沙·沙蒂尔阿尔·帕特尔 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂

Also Published As

Publication number Publication date
WO2019190432A2 (en) 2019-10-03
WO2019190432A3 (en) 2019-11-21
EP3723735A2 (de) 2020-10-21
EP3723735A4 (de) 2021-11-10

Similar Documents

Publication Publication Date Title
US6177102B1 (en) Once daily analgesic tablet
JP5816091B2 (ja) ナトリウムオキシベートの即時放出投薬形態
US7771748B2 (en) Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
US8449910B2 (en) Stable compositions of famotidine and ibuprofen
HUT62488A (en) Process for producing orally administrable pharmaceutical compositions comprising coagulation and platelet function inhibiting active ingredients in small dose
JP2009502987A (ja) カルビドパとレボドパを含有する延長放出型固形医薬組成物
JP7592001B2 (ja) エフロルニチンとスリンダクの固定用量複合製剤
US7303761B2 (en) Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin
US20030147957A1 (en) Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core
US20250235445A1 (en) Novel pharmaceutical formulation
PL190733B1 (pl) Zastosowanie przeciwmigrenowej kombinacji i kompozycja farmaceutyczna do leczenia migreny
WO2011144994A1 (en) Pharmaceutical compositions of nsaid and acid inhibitor
CA2965237C (en) Pharmaceutical capsule containing at least two tablets
US20090202633A1 (en) Extended release formulations of guaifenesin
TR201720293A2 (tr) Tolperi̇zon ve non-selekti̇f cox i̇nhi̇bi̇törü kombi̇nasyonlari
TR201720289A2 (tr) Tolperizon Ve Selektif COX-2 İnhibitörü Kombinasyonları
EP2954895B1 (de) Pharmazeutische kombinationen aus flurbiprofen mit kontrollierter freisetzung und diacerein
CA3085823A1 (en) Pharmaceutical compositions of flurbiprofen and 5-ht1 - receptor agonists
TR201721036A2 (tr) Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari
TR201605632A1 (tr) Flurbi̇profen ve tramadolün yavaş salinimli kombi̇nasyonlari
US20150224056A1 (en) Pharmaceutical compositions of ibuprofen and famotidine
WO2012059937A1 (en) Modifies release pharmaceutical compositons for nsaids
KR20090107960A (ko) 심혈관계 질환 치료용 약제학적 제제
BRPI1103205A2 (pt) Composição farmacêutica oral e uso da composição farmacêutica oral
US20130236538A1 (en) Pharmaceutical compositions of ibuprofen and famotidine